Nurses’ Intention to Integrate AI Into Their Practice: Survey Study in Canada.
September 6, 2025Nurses' AI Integration Intentions: 65% variance explained, trust & beliefs crucial for adoption. 📊🤖
New AI Tools from Penn Enhance Kidney Disease Treatment
September 6, 2025New AI tools from Penn enhance kidney disease treatment by analyzing cellular data for personalized therapies. 🧬💊
Enhancing Oncology-Specific Question Answering With Large Language Models Through Fine-Tuned Embeddings With Synthetic Data.
September 6, 2025Revolutionizing oncology data retrieval: 9% NDCG improvement using LLMs and fine-tuned embeddings! 📊💡
Wearable Point-of-Care Biosensor for Biomolecular Assay in Health Monitoring.
September 6, 2025Wearable biosensors enhance health monitoring, enabling early disease detection through real-time bioanalysis. 📊🔬
MIT Develops New Antibiotics Using AI to Combat Drug-Resistant Infections
September 5, 2025MIT researchers have developed new antibiotics using AI to target drug-resistant bacteria like MRSA and gonorrhea. 🦠💊
Transformative Role of Artificial Intelligence in Drug Discovery and Translational Medicine: Innovations, Challenges, and Future Prospects.
September 5, 2025AI revolutionizes drug discovery, reducing costs by 30% and development time by 50%. Ethical challenges persist. 🤖💊
AI Enhances RNA Vaccine and Therapy Development
September 5, 2025AI aids in designing nanoparticles for RNA vaccine delivery, enhancing efficiency and potential treatments for various diseases. 🧬💉
Lung lobe segmentation: performance of open-source MOOSE, TotalSegmentator, and LungMask models compared to a local in-house model.
September 5, 2025Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. 📊🫁
Interaction of artificial intelligence, mental disorders, and diverse data modalities: Potential treatment management based on the “method-disease-data” axis.
September 5, 2025AI in Mental Health: 3158 entities, 3248 relationships mapped for improved diagnosis & treatment. Challenges remain. 🤖🧠